Vernessa T. Pollard joins the Food and Drug Law Institute (FDLI) to discuss “Minimizing Product and Promotional Digital Health/ Artificial Intelligence Liability Issues.”
Learn more and register here.
Interested in receiving articles on similar topics as they are published? Subscribe for timely email updates or contact us to discuss more…
San Francisco, CA / In-person / April 30, 2026
Health Tech Investment Forum 2026Orlando, FL / Speaking Engagements / April 23 – 24, 2026
NAMCP 2026 Spring Managed Care ForumMiami, FL / In-person / March 4-5, 2026
HPE Miami 2026Las Vegas, NV and Virtual / Speaking Engagements / February 11 – 13, 2026
AHLA Winter Institute 2026: Advising Providers and AI in Health CareWebinar / Webinar / February 3, 2026
Optimizing pharma operations in 340B and beyond: Investor opportunities and compliance considerationsWebinar / Speaking Engagements / January 22, 2026
HIPAA Compliance for Medical Device Companies in the AI Age
